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Apoptosis-beta (TGF-β) induces apoptosis in hepatocytes, through a mechanism mediated
by reactive oxygen species (ROS) production. Numerous tumoral cells develop mechanisms to escape from
the TGF-β-induced tumor suppressor effects. In this work we show that in FaO rat hepatoma cells inhibition
of the epidermal growth factor receptor (EGFR) with the tyrphostin AG1478 enhances TGF-β-induced cell
death, coincident with an elevated increase in ROS production and GSH depletion. These events correlate
with down-regulation of genes involved in the maintenance of redox homeostasis, such as γ-GCS and
MnSOD, and elevated mitochondrial ROS. Nonetheless, not all the ROS proceed from the mitochondria.
Emerging evidences indicate that ROS production by TGF-β is also mediated by the NADPH oxidase (NOX)
system. TGF-β-treated FaO cells induce nox1 expression. However, the treatment with TGF-β and AG1478
greatly enhanced the expression of another family member: nox4. NOX1 and NOX4 targeted knock-down by
siRNA experiments suggest that they play opposite roles, because NOX1 knockdown increases caspase-3
activity and cell death, whilst NOX4 knock-down attenuates the apoptotic process. This attenuation
correlates with maintenance of GSH and antioxidant enzymes levels. In summary, EGFR inhibition enhances
apoptosis induced by TGF-β in FaO rat hepatoma cells through an increased oxidative stress coincident with a
change in the expression pattern of NOX enzymes.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species (ROS) have been considered for years as
toxic molecules generated as by-products during aerobic respiration,
and implicated in different pathologic processes, such as inﬂamma-
tion or aging [1–3]. However, ROS also function as signaling molecules
at physiological concentrations mediating numerous biological pro-
cesses [4,5]. Numerous cytokines and growth factors have been
described to generate ROS to transmit information upon binding totor; γ-GCS, gamma-glutamyl-
H, reduced glutathione; HCC,
mutase; ROS, reactive oxygen
r (COM), IDIBELL, Gran Via s/n
, Spain. Tel.: +34932607355;
l rights reserved.their receptors [5]. In fetal rat hepatocytes, Transforming Growth
Factor-beta (TGF-β) induces cell death through a mechanism
dependent on ROS production [6]. ROS are responsible for the
execution of the mitochondrial pathway of apoptosis [7], at least in
part, through modulation of different members of the Bcl-2 family [8–
10]. TGF-β-induced ROS have two main sources: one mitochondrial,
through down-regulation of antioxidant genes [11,12]; another one
extra-mitochondrial, through NADPH oxidase activation [12]. ROS
production is blocked by the epidermal growth factor (EGF), which
rescues hepatocytes from TGF-β induced-apoptosis [13,14].
During the last years, numerous articles have described the
existence of NADPH oxidase homologues to the phagocytic
gp91phox, currently named NOX2. These proteins are now enclosed
in the NOX family of NADPH oxidases [15]: NOX1 to NOX5, DUOX1
and DUOX2. The enzymatic activity of these NADPH oxidases is
mainly modulated by regulatory subunits or calcium binding [16].
For example, NOX1 and NOX2 depend on Rac activity [17]. An
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or regulatory proteins and only requires p22phox to be active. Thus,
NOX4 activity has been described to be determined only by its
mRNA/protein levels [16].
In normal circumstances, TGF-β is a cytokine responsible for
homeostasis preservation, inducing cell cycle arrest and apoptosis
in different organs, including the liver [18]. In this sense, TGF-β is
considered a tumor suppressor. However, many tumor cells acquire
resistance to the suppressor actions of TGF-β [18] and, under these
circumstances, this cytokine mediates migration, invasion and
metastasis [19–21]. FaO rat hepatoma cells are poorly responsive to
TGF-β-induced apoptosis. Thus, we have recently described that, in
addition to its pro-apoptotic activity, TGF-β also induces anti-
apoptotic signals in FaO rat hepatoma cells, through production of
EGF Receptor (EGFR) ligands that stimulate an autocrine loop of EGFR
activation [22]. One of the main characteristic facts reported during
the development of liver tumors is the acquisition of resistance to
apoptosis and activation of survival signals, favoring an uncontrolled
growth of tumoral cells [23]. Thus, the over-activation of the EGFR
might contribute to the tumorigenic capacity of FaO rat hepatoma cells
and, in fact, the incubation with EGFR inhibitors sensitizes them to
TGF-β-induced cell death [22]. It is interesting to point out that some
reports suggest the effectiveness of EGFR inhibitors as potential
therapy in hepatocellular carcinoma (HCC) models both in vivo and in
vitro [24–26].
Considering all these reports, the aim of this work has been to
analyze the molecular mechanisms of the sensitization of FaO rat
hepatoma cells toTGF-β-induced apoptosiswhen the EGFR pathway is
inhibited. Results might have relevance to understand the potential
consequences of EGFR over-activation in liver tumorigenesis. Our
results suggest that enhanced oxidative stress and a change in the
expression pattern of NOX proteins might be responsible for the
increased cell death.
2. Experimental procedures
2.1. Cell culture conditions
FaO rat hepatoma cells, obtained from the European Collection
of Cell Cultures (ECACC), were cultured in F12 Coon's modiﬁed
medium with 10% FBS. For experiments, cells at 70% conﬂuence
were serum-starvated during 12 h before treatments. Treatments
were as it follows: AG1478 (20 μM) was incubated 30 -β;
Glutathione-ethyl-ester (GEE, 2 or 5 mM); Z-VAD (20 μM), MG132
(1 μM), Rac inhibitor NCS23766 (100 μM) or Apocynin (300 μM)
were added 30 min before AG1478. All these reagents were from
Calbiochem (La Jolla, CA, USA), except GEE and apocynin from Sigma
(Madrid, Spain).
2.2. Cell viability analysis
Cells were seeded in 96-well plates. Multitox-Fluor Multiplex
Cytotoxicity Assay kit (Promega, Madison, USA) reagents were added
after treatments as indicated bymanufacturer's protocol. Fluorescence
was measured in a Microplate Fluorescence Reader Fluostar Optima.
Viability was calculated as the ratio between live cells ﬂuorescence
and dead cells ﬂuorescence, and expressed as percentage of untreated
cells.
2.3. Analysis of caspase-3 activity
Caspase-3 activity was analyzed ﬂuorimetrically as described
previously [7]. Protein concentration of cell lysates was determined
using the Bio-Rad protein assay kit. Results are calculated as units of
caspase-3 activity per microgram of protein and expressed as fold
induction relative to control.2.4. Measurement of intracellular redox state
The oxidation-sensitive ﬂuorescent probes 2′,7′-dichlorodihydro-
ﬂuorescein diacetate (H2DCFDA), MitoSOX™ Red (both from Invitro-
gen, Carlsbad, CA, USA) and Monochlorobimane (from Sigma, Madrid,
Spain) were used to analyze the total intracellular content of ROS,
mitochondrial superoxide production and GSH content, respectively.
After treatment, cells were incubated with 2.5 μM H2DCFDA (30 min,
37 °C), 5 μM MitoSOX™ Red (10 min, 37 °C) or 2 mM Monochlor-
obimane (1 h, 37 °C) in HBSS without red phenol, lysed with a buffer
containing: 25 mM HEPES pH 7.5, 60 mM NaCl, 1.5 mMMgCl, 0.2 mM
EDTA and 0.1% Triton X-100 (10 min, 4 °C) and transferred in duplicate
into a 96-well plate. Fluorescence was measured in a Microplate
Fluorescence Reader Fluostar Optima and expressed as percentage to
control after correction with protein content.
2.5. Analysis of gene expression
RNeasy Mini Kit (Qiagen, Valencia, CA) was used for total RNA
isolation. Reverse transcription (RT) was carried out with oligodeox-
ythymidylate primer using 3 μg of total RNA from each sample for
complementary DNA synthesis. Semiquantitative PCR reactions were
performed using rat speciﬁc primers: γ-gcs (for: 5′TGGATTCACA-
CTGCCAGAGC3′; rev: 5′CACCTGAAGACAGCAGTTGC3′), mn-sod (for: 5′
TTCAGCCTGCACTGAAG3′; rev: 5′GTCACGCTTGATAGCCTC3′), hemo-
oxigenase (for: 5′CTGCTAGCCTGGTTCAAGATA3′; rev: 5′CATCTCCTTCC
ATTCCAGAG3′), l-ferritin (for: 5′AGAAGCCATCTCAAGATGAG3′; rev: 5′
CTAGTC GTGCTTCAGAGTGA3′), h-ferritin (for: 5′CCAGTAAAGTCAC-
ATGGCCT3′; rev: 5′GGCTACTGACAAGAATGATC3′), and albumin (for:
5′CTGCCGATCTGCCCTC AATAGC3′; rev: 5′GTGCCCACTCTTCCCAGGT-
TTCT3′). PCR products were obtained after 30–35 cycles of ampliﬁca-
tion at annealing temperatures of 57–62 °C, and analyzed by 1.5%
agarose gel electrophoresis. Expression of albumin was analyzed as a
loading control. The −RT channel contained RNA that had not been
treated with the RT mixture and is shown as a speciﬁcity control.
For Real-Time quantitative PCR, expression levels of nox1 and nox4
and housekeeping gadph mRNAs were determined in duplicate in an
ABIPrism7700 System following manufacturer's protocol. Pre-
designed Taqman® primers for nox1 (Rn00586652_m1), nox4
(Rn00585380_m1) and gapdh (Rn99999916_s1) and Taqman® Uni-
versal Master Mix were used. All real time reagents were from Applied
Biosystems (Foster City, CA, USA).
2.6. Knock-down assays
For transient siRNA transfection, cells at 70% conﬂuence were
transfected using TransIT-siQuest (Mirus, Madison, USA) at 1:300
dilution in complete medium, according to the manufacturer's
recommendation, with a ﬁnal siRNA concentration of 25 nM during
8 h. After 16 h of incubation in complete medium, cells were
trypsinized and seeded for experiments. Oligos were obtained from
Sigma-Genosys (Suffolk, UK). The oligo sequences were as follows:
(unsilencing) 5′GUAAGACACGACUUAUCGC3′, (nox4) 5′ AGACCUG-
GCCAGUAUAUUA3′, (nox1) 5′UCAUAUCAUUGCACAUCUA3′. The unsi-
lencing siRNA used was selected from previous works [27]. Speciﬁc
oligos with maximal knock-down efﬁciency were selected among
three different sequences for each gene.
2.7. Western blot analysis
Total protein extracts were obtained using a lysis buffer containing
30 mM Tris–HCl pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100,
0.5% sodium deoxycolate, 0,1% SDS and 10% glycerol. Pellets were
incubated during 1 h in lysis buffer at 4 °C, sonicated 5 s, boiled 5 min
and centrifuged at 13000 rpm during 10 min at 4 °C. Western blot
procedurewas carried out as described previously [22]. The antibodies
Fig. 1. Inhibition of the EGF receptor enhances cell death induced by TGF-β. (A) Cells
were treated as indicated during 12 h, and caspase-3 activity was measured. Mean
±SEM of three independent assays. (B) Cellular viability upon 24 h of the indicated
treatments. Data are mean±SEM of three independent experiments with triplicate
wells, and they are calculated as percentage of untreated cells. Comparative kinetics of
ROS production (C) and GSH (D). Kinetic measurement at the indicated times of
treatment with TGF-β, AG1478 or TGF-β and AG1478. Graphics represent the mean
±SEM of four independent experiments, with triplicate wells in case of ROS production
determinations. Results are shown as percentages of control (untreated cells). Student's
t test versus TGF-β-treated cells: *pb0.05; **pb0.01.
Fig. 2. Glutathione-ethyl-ester (GEE) attenuates cell death induced by TGF-β alone or in
combination with AG1478. (A) Caspase-3 activity was measured upon 16 h of the
indicated treatments. Mean±SEM of three independent assays. (B) Cells were treated
during 24 h and cell viability was analyzed. Data are calculated as percentage of
untreated cells and are mean±SEM of three independent experiments with triplicate
wells. Student's t calculated between cells with or without the indicated concentrations
of GEE: *pb0.05; **pb0.01.
255P. Sancho et al. / Biochimica et Biophysica Acta 1793 (2009) 253–263used were: mouse anti-β-actin (clone AC-15; Sigma, Madrid, Spain);
rabbit anti-gamma glutamylcysteine syntethase (Abcam, Cambridge,
UK), rabbit anti-MnSOD (06-984 Upstate, Lake Placid, NY, USA), rabbit
anti-NOX1 (H-75, Santa Cruz Biotechnology, CA,USA). Anti-NOX4rabbit polyclonal antiserum was raised by Sigma-Genosys against a
peptide corresponding to the C-terminal loop region (aminoacids
499–511). Speciﬁcity was tested by ELISA assay with the puriﬁed
peptide. Antibodies were used at 1:1000, except β-actin (1:3000).
Protein concentration was measured with BCA™ Protein Assay kit
(Pierce, Rockford, USA).
3. Results
3.1. Inhibition of the EGF receptor enhances oxidative stress in response
to TGF-β
As we previously described [22], TGF-β induced cell death in FaO
rat hepatoma cells. However, the inhibition of the EGF receptor with
AG1478 greatly enhanced the apoptotic response, measured as
caspase-3 activity (Fig. 1A), coincident with an increased loss of cell
viability (Fig. 1B). We have reported that TGF-β induces oxidative
stress in fetal rat hepatocytes, and that this stress is necessary to
execute cell death [6]. We ﬁrst wanted to knowwhether the cell death
mechanism induced by TGF-β was analogous in FaO cells, and
whether the inhibition of the EGFR was affecting cells in this sense.
In order to do this, we studied the total ROS production and reduced
glutathione (GSH) content kinetically. We found that TGF-β induced
ROS production transiently, with a maximum peak after 12 h (Fig. 1C),
coincident with caspase-3 activation. Moreover, ROS production
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incubated with AG1478, ROS production and GSH drop induced by
TGF-β were signiﬁcantly augmented (Fig. 1C and D), even though
AG1478 by itself caused oxidative stress to some extent. In addition,
pre-incubation with a permeable form of GSH (glutathione-ethyl-Fig. 3.Down-regulation of γ-GCS andMn-SOD by the combination of TGF-β and AG1478. (A,B
β at the indicated times. In B, cells were treated with TGF-β and/or AG1478 for 12 h. (C) W
weights for γ-GCS (73) and its cleaved form (60) is shown. In all cases, graphs represent the m
β-actin, used as loading control for RT-PCR andWestern blot, respectively. Student's t test ve
used. In all cases, a representative experiment of three is shown.ester, GEE) inhibited both caspase-3 activity and loss of viability
induced by TGF-β alone or in combination with the EGFR inhibitor
(Fig. 2). The efﬁcient concentration of GEE to inhibit cell death was
related to the degree of oxidative stress induced. All these results
indicate that EGFR inhibition enhanced TGF-β-induced apoptosis) Semiquantitative RT-PCR. In A, cells were serum-depleted (Cont) and treatedwith TGF-
estern blot at the indicated times of treatment with TGF-β and/or AG1478. Molecular
ean±SEM of densitometric analysis of the indicated genes or proteins versus albumin or
rsus untreated cells: *pb0.05; **pb0.01. For Western blot, 50 μg of protein per lane were
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responsible for cell death.
3.2. TGF-β and EGFR inhibitor induced a decrease of antioxidant defenses
and an increment of mitochondrial ROS
Next, we wanted to determine the cellular source of ROS
production induced by TGF-β alone or in combination with the
EGFR inhibitor. First, we decided to study the expression of genes
involved in antioxidant defenses upon treatment with TGF-β, because
we and others had previously described them to be involved in TGF-β-
induced apoptosis [11,12,28]. TGF-β induced in FaO cells a slight
decrease in the expression of gamma-Glutamylcysteine Synthetase
(γ-gcs, the main regulatory enzyme of the glutathione synthesis) with
no changes in the expression of the other analyzed genes (Fig. 3A, and
data not shown). The inhibition of the EGFR ampliﬁed and accelerated
the down-regulatory effect of TGF-β on γ-gcs mRNA levels and,
interestingly, it decreased mn-sod expression (Fig. 3B). We also could
observe a diminution in γ-GCS at the protein level and the appearance
of a processed band of γ-GCS, described as a product of degradation
by caspases [11]. Both effects were more accentuated and could be
detected at an earlier stage when AG1478 was present (Fig. 3C).
Furthermore, and according to the results obtained in the RT-PCR
experiments, Mn-SOD protein levels only decreased signiﬁcantly after
treatment with the combination of TGF-β and AG1478.Fig. 4. Contribution of mitochondria to intracellular ROS produced by TGF-β with or
without AG1478. (A) Comparative measure of ROS production with H2DCFDA and
MitoSOX Red at 16 h of the indicated treatments. Student's t test H2DCFDA versus
MitoSOX in the different treatments: **pb0.01. (B) Cells where treated as indicated with
or without Z-VAD during 16 h, and MitoSOX Red ﬂuorescence was determined. Results
are shown as percentages of control (untreated cells), calculated from at least three
independent experiments with triplicate wells. Student's t test calculated as cells
treated with Z-VAD versus cells without Z-VAD: **pb0.01.As we observed a situation where the mitochondria were
unprotected due to the lack of antioxidants, we decided to quantify
the contribution of the mitochondrial ROS to the total ROS amount,
using a mitochondrial superoxide anion speciﬁc ﬂuorescent probe
(MitoSOX red) (Fig. 4A). In the case of TGF-β, we could not detect any
signiﬁcant difference between the two probes. AG1478 per se induced
an increase in ROS levels that were mostly originated outside of the
mitochondria, because MitoSOX-derived ﬂuorescence was barely
increased in this case. When cells were co-treated with AG1478 and
TGF-β, about two thirds of the total ROS amount came from
mitochondria, but there was an important amount of ROS from an
extra-mitochondrial source of ROS as well. Interestingly enough, the
use of Z-VAD, the general caspase inhibitor, almost completely
abrogated the increase of MitoSOX ﬂuorescence induced by the
combination of TGF-β and AG1478 (Fig. 4B). In summary, the co-
treatment with TGF-β and the EGFR inhibitor induced a decrease of
antioxidant defenses which correlated with an increment of mito-
chondrial ROS, possibly through an earlier caspase activation.
However, there was another source of ROS, since the total amount of
ROS was higher than that detected from mitochondria.
3.3. NOX1 and NOX4 are differently regulated by TGF-β alone or in
combination with AG1478
Looking for the origin of extra-mitochondrial ROS, we ﬁrst thought
about a possible implication of NADPH oxidases, since there are
distinct isoforms of NADPH oxidases expressed in fetal hepatocytes:
nox1, nox2 and nox4, this last one inducible by TGF-β [29]. For this
reason, we decided to analyze the expression levels of these NADPH
oxidases upon treatment with TGF-β. Preliminary analysis revealed
that nox1 and nox4 are the only nox genes expressed in FaO rat
hepatoma cells (results not shown). We have previously described
that EGF blocks nox4 expression in fetal hepatocytes [13], and,
knowing that FaO cells show high basal activation of the EGFR [22],
we studied the expression levels of nox1 and nox4 in cells treated with
TGF-β, combined or not with AG1478, by Real Time PCR. Both NADPH
oxidases were slightly up-regulated by TGF-β, and this up-regulation
became highly remarkable when AG1478 was added (Fig. 5A, B).
However, it is important to note that nox1 expression was easily
detected by Real-Time PCR, but it was necessary to use a large amount
of cDNA to detect nox4. We conﬁrmed by Western blot the results
obtained by Real-time PCR for NOX4 (Fig. 5A, right panel). However,
the case of NOX1 was different. We conﬁrmed the result for TGF-β-
treated cells, but no increase in protein levels was observedwhen cells
were treatedwith the combination of TGF-β and AG1478 (Fig. 5B, right
panel). In order to resolve the discrepancy between the results
obtained by Real-Time PCR and Western blot, we pre-incubated the
cells with a proteasome inhibitor, MG132, prior to TGF-β and AG1478.
As shown in Fig. 5C, NOX1 levels were increased when MG132 was
present, suggesting that treatment with TGF-β and AG1478 promoted
NOX1 degradation by the proteasome. In summary, NOX1 and NOX4
expression was regulated by TGF-β, but when the EGFR inhibitor was
present, only NOX4 was up-regulated at the protein level.
3.4. NOX1 and NOX4 are differently implicated in the apoptosis induced
by TGF-β alone or in combination with AG1478
In order to study the possible role of these proteins in our system,we
decided to use a targeted knock-down by a siRNA approach to down-
regulate their expression. Surprisingly, we found opposite results when
we knocked-down NOX1 or NOX4. While NOX4 knock-down inhibited
the loss of cell viability and the activation of caspase-3 induced by TGF-β
and AG1478 to levels comparable to those obtained with TGF-β alone
(Fig. 6C, D), NOX1 knock-down enhanced cell death by TGF-β alone or in
combinationwithAG1478 (Fig. 7C, D).Wedetected anattenuation in the
increase of total ROS production induced by co-treatment with TGF-β
Fig. 5. Regulation of NOX1 and NOX4 expression by TGF-β alone or in combinationwith AG1478. (A) NOX4 levels determined by Real-Time PCR (left) or Western blot (right) at 10 h of
treatment with TGF-β alone or in combination with AG1478. (B) NOX1 levels determined by Real-Time PCR (left) or Western Blot (right) at 10 h of treatment with TGF-β alone or in
combination with AG1478. (C) Western blot analysis of NOX1 in presence or absence of 1 μM of the proteasome inhibitor MG132 during 4 h. For Western blot, 30 μg per lane were
charged and β-actin was used as loading control. Graphs represent the mean±SEM of data from densitometric analysis of three different experiments. Student's t test versus
untreated cells: *pb0.05; **pb0.01.
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this last one the decrease was more pronounced (Figs. 6B, 7B). Even
though both NOX1 and NOX4 knock-down decreased ROS production,
the effects on the global oxidative status of the cell was different: NOX4
knock-down, but not NOX1 knock-down, almost completely impaired
the drop inGSH intracellular levels (Fig. 8A) andattenuated thedecreasein Mn-SOD and γ-GCS levels induced by co-treatment with TGF-β and
AG1478 (Fig. 8B). We decided to conﬁrm the results obtained with the
speciﬁc NOX1 siRNA using two inhibitors of the NADPH oxidase family
that only affect NOX1 but not NOX4 activity. In agreement with recent
publications describing that NOX4 activity is independent from
regulatory proteins [30],weused apocynin, an inhibitorof the formation
Fig. 6.NOX4 targeted knock-down, by siRNA experiments, inhibits cell death induced by
TGF-β with AG1478. Cells transfected with either an unspeciﬁc siRNA (Uns. siRNA) or
the speciﬁc NOX4 siRNA were treated with TGF-β and/or AG1478 for 16 h and it was
determined: nox4 relative expression by Real-Time PCR (A); total ROS production (B);
caspase-3 activity (C) and cell viability (D). All data were calculated relative to untreated
cells transfected with unsilencing siRNA. Data represents the mean±SEM of six
independent experiments. Student's t test calculated as unsilencing siRNA versus
speciﬁc siRNA in each treatment: *pb0.05; **pb0.01.
Fig. 7. NOX1 targeted knock-down, by siRNA experiments, enhances cell death induced
by TGF-β alone or in combination with AG1478. Cells transfected with either an
unspeciﬁc siRNA (Uns. siRNA) or the speciﬁc NOX1 siRNAwere treated with TGF-β and/
or AG1478 for 16 h. nox1 relative expression by Real-Time PCR (A); total ROS production
(B); caspase-3 activity (C) and cell viability (D) were measured. All data were calcu-
lated relative to untreated cells transfected with unsilencing siRNA. Data represent the
mean±SEM of four independent experiments. Student's t test calculated as unsilencing
siRNA versus speciﬁc siRNA in each treatment: *pb0.05; **pb0.01.
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also used a Rac1 inhibitor, because it was described that NOX1 needs
Rac1 to be activated [18]. We found that apocynin and Rac1 inhibitor
reproduced the results obtained with NOX1 knock-down: decreased
total ROS production (Fig. 9A, B) and enhanced caspase-3 activity
(Fig. 9C). These results suggest that NOX1 and NOX4 play differential
roles in the apoptotic signaling induced by TGF-β in FaO rat hepatoma
cells.
4. Discussion
For many years, reactive oxygen species have been considered as
simple cellular damaging agents, implicated in numerous cell deathmodels. However, in the last years, this idea has evolved to the concept
of a highly regulated physiological role in cell signaling. Most cell
types have been shown to produce low concentrations of ROS when
they are stimulated by cytokines, growth factors and hormones [5],
and it is generally accepted that ROS induced by these stimuli function
as true secondmessengers andmediate functions such as proliferation
and cell death [32].
TGF-β is thought to exert its pro-apoptotic activity through the
generation of ROS prior to caspase activation in hepatocytes [6–8,33].
One of the proposed mechanisms is the down-regulation of
Fig. 8. NOX4 targeted knock-down inhibits GSH depletion and antioxidant enzymes down-regulation induced by TGF-β in combinationwith AG1478. Cells transfected with either an
unspeciﬁc siRNA (Uns. siRNA) or the speciﬁc NOX1 siRNA or NOX4 siRNA, were treated with TGF-β and/or AG1478 for 16 h. (A) GSH intracellular level. (B) Western blot analysis of γ-
GCS andMn-SOD. Graphs represent the mean±SEM of data from densitometric analysis of three different experiments. Student's t test calculated as unsilencing siRNAversus speciﬁc
siRNA in each treatment: *pb0.05; **pb0.01.
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gamma-glutamylcysteine synthetase, the rate-limiting enzyme for
GSH biosynthesis [11,12,28]. This is also the mechanism found in other
cell types, such as beta-pancreatic cells [34]. According to these
reports, our results indicate that TGF-β induces apoptosis in FaO cells
through a ROS-dependent mechanism (Figs. 1 and 2). In this model,
ROS production can be detected at an early stage, concomitant to
caspase-3 activation. We also ﬁnd an important decrease of GSH that
correlates with a γ-GCS reduction at protein level (Fig. 3C). Indeed, the
production of mitochondria-derived ROS is almost equivalent to
the total ROS amount (Fig. 4A), which makes us think of a great
implication of this organelle according to the classical view of the
mitochondria as the main source of ROS [35]. Moreover, the existence
of a redox regulation of hepatocyte apoptosis through mitochondrial
dependent processes is widely accepted [36,37]. However, it is worthy
to point out that the apoptotic mechanism induced by TGF-β alone is
not very efﬁcient in FaO cells, and a great proportion of them surviveand respond to TGF-β inducing an epithelial-mesenchymal transition
process [22].
It has been described that EGF impairs TGF-β-induced apoptosis in
hepatocytes and hepatoma cells [14,38], and that the EGFR transacti-
vation by TGF-β mediated pro-survival effects of this cytokine in
different cell lines, including FaO rat hepatoma cells [22,39–41]. Data
reported in this work indicate that sensitization to TGF-β-mediated
apoptosis by the EGFR inhibitor AG1478 is dependent on the
ampliﬁcation of ROS production induced by TGF-β (Figs. 1 and 2). In
fact, we observe an intensiﬁcation of about three-fold and a rapid drop
of GSH content. This ampliﬁcation can be explained in part by the fact
that antioxidant enzymes are greatly down-regulated at 12 h of
treatment (Fig. 3B, C). The lack of Mn-SOD and the drop of GSH
content would leave the mitochondria unprotected against its own
normal respiratory function, favoring mitochondrial damage and
caspase cascade initiation [42,43]. The rapid appearance of a
degradation band of γ-GCS at the described molecular weight for
Fig. 9. Apocynin and Rac1 inhibitor mimic NOX1 knock-down effects on cell death. Cells
were treated for 16 h with TGF-βwith or without AG1478 and in presence or absence of
apocynin (300 μM) or Rac1 inhibitor NCS23766 (Rac Inh; 100 μM). (A, B) Total ROS
production. (C) Caspase-3 activity. Data (mean±SEM of three independent experi-
ments) are calculated respect to untreated control. Student's t test calculated as cells
treated with apocynin or Rac1 inhibitor versus cells without the inhibitors in each
treatment: *pb0.05; **pb0.01.
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part of mitochondrial ROS by Z-VAD (Fig. 4B), suggest an ampliﬁed
mitochondrial dysfunction possibly provoked by an early caspase
activation. Indeed, an ampliﬁcation loop has been described involving
the cleavage of different Bcl-2 proteins, such as BAD, BID, and BCL-XL,
by early caspase activation induced by TGF-β [9,10,44]. However,
the complete ROS content induced by the treatment cannot be only
explained by mitochondrial events, since we observe a portion
which would correspond to an extra-mitochondrial source of ROS
not detected by the mitochondrial probe (Fig. 4A).
The acceptance of an involvement of reactive oxygen species on
physiological processes in cells has grown since the NOX family of
NADPH oxidases has been discovered for homology to gp91 phox, the
phagocytic oxidase. These enzymes arewidely expressed in numerous
tissues and play different roles including cell signaling, gene
expression regulation, cell death, differentiation and growth
[15,17,45]. For instance, different members of the NADPH oxidasefamily have been recently related to TGF-β-induced signaling in
different models. Effects in differentiation of cardiac ﬁbroblasts [46],
proliferation of pulmonary artery smooth cells [47] and nephrotoxicity
[48] are controlled by a TGF-β-NADPH oxidase-dependent pathway.
In recent works of the group, we have reported that TGF-β induced
nox4 up-regulation and cell death in fetal hepatocytes, this effect
being impaired by EGF addition [13]. In FaO cells, which show over-
activation of the EGFR pathway [22], nox4 is not efﬁciently induced by
TGF-β. Only when we inhibit the EGF receptor an up-regulation of
nox4 is detected at mRNA and protein levels (Fig. 5A). In FaO cells
the situation could be different as compared to fetal hepatocytes due
to the high autocrine transactivation of the EGFR in response to TGF-β
[22], which would act similarly as EGF addition in fetal hepatocytes:
repressing nox4 expression and apoptosis. Actually, knock-down
experiments show that if we eliminate nox4, the apoptosis induced
by TGF-β alone or TGF-βwith AG1478 is equivalent (Fig. 7). NOX4 pro-
apoptotic role might be related to the global oxidative stress induced
by TGF-β. It has been interesting to ﬁnd thatMn-SOD and γ-GCS levels
are not down-regulated by the combination of TGF-β and AG1478
when NOX4 is knocked-down, and GSH depletion is almost com-
pletely prevented (Fig. 8). NOX4 activity has been described to be
determined by mRNA levels, independently from regulatory events
[30], and to localize in intracellular membranes, such as endoplasmic
reticulum [47,49]. Upon cell stimulation, up-regulation of NOX4 in this
localization might generate ROS which would impede the correct
translation and/or folding of several proteins, including antioxidant
enzymes. In addition to nox4, we ﬁnd an up-regulation of nox1 at the
mRNA level in response to TGF-β, which is signiﬁcantly higher when
AG1478 is present (Fig. 5B). However, it was intriguing to observe that
no increase in protein levels is observed when AG1478 and TGF-β act
together. The increase of NOX1 protein levels when cells are treated in
the presence of the proteasome inhibitor MG132 should indicate that
EGFR transactivation is required for a full TGF-β positive regulatory
effect on NOX1, which might regulate its expression through
transcriptional and translational mechanisms. Nevertheless, and in
contrast to NOX4, NOX1 is not constitutively active. Its activation
depends on different cytosolic components, such as p22 [50], NOXO1
and NOXA1 [51] and Rac [17]. Although the combination of AG1478
and TGF-β does not generate an increase in NOX1 protein, its function
might be relevant, since targeting knock-down with NOX1 siRNA
produces signiﬁcant depletion in ROS production and, interestingly,
enhancement of cell death (Fig. 7). Similar effects are observed with
apocynin or a Rac1 inhibitor (Fig. 9).
Various articles have been published about the role of NOX
proteins in cell survival or apoptosis. Different reports have linked
NOX1 and NOX4 to apoptosis or survival in many cellular models and
we can conclude that signals involving NOX seem to be tissue- and
stimuli-speciﬁc. On the one hand, NOX4 is involved in apoptosis in
human aortic smooth muscle cells [47], leukemia cells [52] and
macrophages [53], but it acts as a pro-survival signal for pancreatic
cells against different stimuli [54,55]. On the other hand, NOX1 is
related to apoptosis in different tissues [56] and cell lines [57–59]; but
it is also reported to be implicated in cell survival in epithelial cells
[60,61] and it is overexpressed in colon adenoma and adenocarcino-
mas [62]. In adult rat hepatocytes, it has been described an
involvement of NADPH oxidase isoforms and apoptosis upon different
stimuli [63,64]. However, NADPH oxidases also control some survival
signals in response to TGF-β in fetal hepatocytes, as we have recently
found [30]. In our model, we ﬁnd, by knock-down experiments, that
nox1 and nox4 play different roles: nox4 mediating cell death, and
nox1 favoring cell survival. In fact, TGF-β-treated cells up-regulate
NOX1, which would have a protective effect, but when the pro-
survival signaling pathway of this cytokine through EGFR is blocked, a
change in the NOX expression pattern occurs: NOX1 up-regulation is
not observed at the protein level and NOX4 expression is enhanced,
coincident with an increase in cell death. Thus, the proteasomal
262 P. Sancho et al. / Biochimica et Biophysica Acta 1793 (2009) 253–263degradation of NOX1 protein in cells treated with TGF-β and AG1478
might be acting as an additional pro-apoptotic mechanism, as
described for classical anti-apoptotic proteins, such as Bcl-2 and
Mcl-1 [65,66].
In summary, the results presented in this paper indicate that
inhibition of the EGFR enhances ROS production and modiﬁes NOX
expression pattern, increasing the pro-apoptotic effect of TGF-β in
hepatoma cells. The enhancement of mitochondrial ROS-dependent
damaging process, NOX4 up-regulation, and impairment of NOX1
increase at the protein level, would make the pro-apoptotic
mechanism induced by TGF-β more efﬁcient when the EGFR is
inhibited.
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